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Abstract The transcriptional start site of the human cholecys-
tokinin (CCK)-A receptor gene was determined by the Capsite
Hunting method. Two sequence changes were detected, a G to T
change in nucleotide 3128, and an A to G change in nucleotide
381. The homozygote (T/T, G/G) was detected in 25 of 1296
individuals (1.9%) in the cohort study. This polymorphism
showed a significantly higher percent body fat and higher levels
of serum insulin and leptin, compared with wild type and
heterozygotes. Our study provided the possibility that poly-
morphism in the promoter region of the CCK-A receptor gene
may be one of genetic factors affecting fat deposition.
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1. Introduction
Cholecystokinin (CCK) is known as an essential gastroin-
testinal hormone, as well as an important neurotransmitter.
Two types of cholecystokinin (CCK) receptors (type A and
type B) have been identi¢ed on the basis of their a⁄nities for
a structurally and functionally related family of peptides with
identical COOH-terminal pentapeptide sequences [1]. These
receptors were cloned recently, and the CCK-B receptor
(CCK-BR) gene was found to be identical to the gastrin re-
ceptor gene [2,3]. CCK-A receptor (CCK-AR) has been dem-
onstrated to be present in the vagus nerve and localized areas
of the central nervous system, and mediates the satiety e¡ect
[1,4]. In addition, it is present in the gastrointestinal system,
mediating pancreatic growth and enzyme secretion, as well as
smooth muscle contraction of the gallbladder and stomach.
Abnormalities in gallbladder contraction in response to exo-
genously administered CCK have been observed in patients
with irritable bowel syndrome, suggesting a generalized ab-
normality of smooth muscle function and possibly altered
CCK-AR function and structure.
Many genetic and environmental factors are considered to
be responsible for obesity. Recently, we demonstrated absence
of the CCK-AR gene expression due to a genetic abnormality
in OLETF rats, which show obesity and non-insulin depen-
dent diabetes mellitus (NIDDM), although the expression of
CCK-BR gene was intact [5,6]. Administration of intracere-
broventricular CCK failed to inhibit food intake in this model
[4]. Thus, dysfunctional CCK-AR may cause human disorders
such as hyperphagia, obesity, hyperglycemia and gallstone
disease. However, mutations of human CCK-AR gene appear
to be rare [7,8].
The transcriptional start site of the human CCK-AR gene
has not been determined. In the present study, we cloned and
sequenced the 5P upstream region of human CCK-AR gene
using a method to replace the cap structure of a mRNA with
an oligoribonucleotide (rOligo) to label the 5P end of eukary-
otic mRNAs [9]. Identi¢cation of the 5P end of mRNA is an
indispensable step for establishing the promoter region of a
gene. Two sequence changes were detected in this promoter
region. We also examined the polymorphism of the CCK-AR
gene promoter, this is associated with obesity (body fat con-
tent), in 1296 individuals between 40^79 years of age.
2. Materials and methods
2.1. RNA extraction
Samples of healthy gallbladder were obtained at surgery from pa-
tients with adenocarcinoma of the pancreas. Informed consent was
obtained for all subjects prior to the operation. Immediately after
removal of the healthy gallbladder, one part was used for histological
examination, whereas the other part was rapidly frozen at 380‡C. All
samples were evaluated histopathologically, and no signs of abnor-
malities or in£ammations were detected. Total RNA was extracted
according to the acid-guanidium thiocyanate-phenol-chloroform
method. The quantity and purity of RNA were determined from
the absorbances at 260 and 280 nm. Ribosomal RNA bands were
visualized under ultraviolet light after ethidium bromide staining.
Samples showing no signs of degradation were employed for Northern
transfer analysis using cDNA probes of the coding regions of the
human CCK-AR [10] and L-actin cDNA (Wako Chemical Industries,
Osaka, Japan); the former probe was kindly provided by Dr. S.A.
Wank, NIH, Bethesda, MD, USA.
2.2. Determination of the transcription start site
Human genomic DNA library (Stratagene, USA) was screened us-
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ing the cDNA probe of the coding regions of the human CCK-AR.
Approximately 1000 000 phage clones were screened under standard
plaque hybridization conditions. Fourteen positive phage clones were
isolated, and further characterized by Southern blot analysis and re-
striction mapping. DNA fragments, which hybridized with the cDNA
probe of CCK-AR, were isolated from lambda H24 and H14 phage
clones and subcloned into M13 mp19 for further shotgun sequencing
method. Sequence data were linked using the inherit sequence analysis
system (Perkin-Elmer, USA).
To determine the transcription start site of human CCK-AR
mRNA, a Capsite Hunting method was used in accordance with
manufacturer’s protocol (Nippon Gene, Tokyo, Japan). Brie£y, the
5P-terminal m7GpppN cap structure was removed by pyrophos-
phorolysis reaction of tobacco nucleotide acid pyrophosphatase and
recapped with the 3P end of a 35 mer-speci¢c oligonucleotide
(rOligo) (5P-GAUGCUAGCUGCGAGUCAAGUCGACGAAGUG-
CAGG-3P) by an RNA ligase reaction. A single-strand cDNA library
was prepared from the recapped mRNA by the synthesis of ¢rst-
strand cDNA with Moloney murine leukemia virus reverse transcrip-
tase and random primer. To amplify CCK-AR-speci¢c transcripts
from single-strand cDNA library, nested PCR was performed. The
¢rst round of PCR was performed using a sense DNA primer com-
plementary to rOligo (RC1, 5P-GATGCTAGCTGCGAGTCAAGTC-
3P) paired with target-gene speci¢c primer 1 (TGS-1, 5P-GTGAT-
GACCAGCGTGTTTCCC-3P). The second PCR was performed us-
ing a sense DNA primer complementary to rOligo (RC2, 5P-CGA-
GTCAAGTCGACGAAGTGC-3P), paired with target-gene speci¢c
primer 2 (TGS-2, for 5P-CACGCTGAGCAGGAATATCAAG-3P).
A single band of second round PCR product was isolated and sub-
cloned into pGEM-T vector, and two independent clones were se-
quenced. The transcription start site was determined by identi¢cation
of the boundary sequence between rOligo and CCK-AR mRNA se-
quences.
2.3. Subjects
The subjects consisted of 646 males and 650 females between 40 and
79 years of age. This cohort study was approved by the National
Institute for Longevity Sciences-Longitudinal Study of Aging. In-
formed consent was obtained for all subjects prior to testing. Body
mass index (BMI) was calculated by dividing the weight by height
squared. Body fat percent was measured both by dual energy X-ray
absorptiometry (DXA). Fasting serum leptin and insulin were meas-
ured by RIAs using the LINCO kit (St Louis, MO, USA) and Dina-
bot kit (Tokyo, Japan), respectively. Genomic DNA was prepared
from leukocytes according to established procedures.
3. Results and discussion
Lambda H24 and H14 cover the 21.8 kb genomic sequence
that contains the entire region of CCK-AR gene according to
previously reported cDNA sequences [7,10]. These sequences
were shown in the GenBank database under accession number
D85606. The sequence of CCK-AR gene digested by PvuII,
including exon 1 as well as the approximately 900 bp 5P-£ank-
ing sequences of CCK-AR gene are partially shown in Fig. 1.
There were no di¡erences between the Japanese and Cauca-
sian individuals. The Capsite Hunting method showed that
the transcription start site is 205 bp upstream of the initiating
ATG (Fig. 1). The ¢rst base in the mRNA is labelled +1, and
the ¢rst base downstream of the promoter is labelled 31. This
is the ¢rst report identifying the transcription start site of
human CCK-AR. The ¢rst 400 bp are rich in GC content
and lack the typical TATA-box motif.
The polymorphisms of promoter region were examined by
the PCR-cloning method using sense primer (nucleotides
3351 to 3332, 5P-TTCTAAGCTTAAGGAGGTAGAACA-
CAGTCC-3P) and antisense primer (nucleotides +197 to
+176, 5P- TTCTGAATTCGCTGCTTTCCACCAAGTGC-
Fig. 1. Exon mapping and nucleotide sequence of the 5P-£anking region of the human CCK-A receptor gene. Closed boxes in the genomic
DNA show exons which are numbered below. The transcriptional initiation site determined by the Capsite Hunting method was assigned as
+1. The positions of sense and antisense primers used for the polymorphism determination are underlined. Asterisks indicate the nucleotide
change positions (G to T change in nucleotide 3128, and an A to G change in nucleotide 381. The coding region in exon 1 was boxed. These
genomic sequences have been deposited in the GenBank database under accession number D85606.
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TGG-3P) from leukocyte genomic DNAs. PCR products were
isolated and cloned into M13, and 10 independent clones were
sequenced. Two sequence changes were detected, a G to T
change at nucleotide 3128, and an A to G change at
nucleotide 381. Therefore, we developed a mismatch PCR-
restriction fragment length polymorphism (RFLP) method in
order to analyze the polymorphism of the CCKAR gene
promoter region. A pair of primers, sense primer = 5P-GC-
ATATGTACACATGTGTGTAAAAAGCAGCCAGAC-3P,
anti-sense primer = 5P-GCCCTTTCCTGGGCCAGACT-3P)
was designed to amplify the 103 bp product, which was
subsequently digested with restriction enzyme HinfI, and
analyzed by 12% polyacrylamide gel electrophoresis. Six geno-
types were identi¢ed as a wild type (G/G, A/A), heterogeneous
mutant types (G/T, A/G), (G/G, A/G), (G/T, G/G), (G/G,
G/G), and a homogeneous mutant type (T/T, G/G), respec-
tively (Fig. 2).
Leptin is a serum protein, which is secreted by adipocytes
and considered to play a role in the regulation of body fat.
Human leptin levels have found to be signi¢cantly correlated
with total adipose levels [11]. In our cohort study, serum
leptin levels signi¢cantly correlated with serum insulin
(r = 0.26, P = 0.0001), BMI (r = 0.54, P = 0.0001) and body
fat content (r = 0.74, P = 0.0001), respectively. This homozy-
gote of the CCK-AR gene promoter polymorphism (T/T,
G/G) was detected in 25 of 1296 (1.9%) individuals between
40^79 years of age and showed a signi¢cantly higher percent
body fat and higher levels of serum leptin and insulin com-
pared with wild and heterogeneous mutant types (Table 1).
Increased insulin levels suggest the insulin resistance is due to
increased body fat content. BMI showed higher levels, but
these were not signi¢cant. These results suggest that polymor-
phism of the CCK-AR gene is related to the increase in body
fat content associated with weight control di⁄culties in obese
subjects, and is a¡ected by lifestyle as well as eating habits.
Therefore, polymorphism in the promoter region of the CCK-
AR gene may be one of the genetic factors that a¡ect obesity
(fat deposition).
The real mechanism of relationship of CCK-AR polymor-
phism and obesity has not been clari¢ed, yet. Many CG-rich
segments are observed in the CCK-AR promoter region and
nucleotide 3128 position was found to be methylated. Thus, a
G to T change in nucleotide 3129 may a¡ect the gene expres-
sion of CCK-AR [12]. The xenobiotic responsive element
(XRE) motif (CACGCW) [13] is also observed in the CCK-
AR promoter region around the 3128 position (CACGCT-
GA). Further functional studies to assess the potential bio-
logical consequences of this CCK-AR gene promoter poly-
morphism are in progress in our laboratory.
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Fig. 2. PCR-RFLP assays of the CCK-A receptor gene promoter.
The promoter PCR products (103 bp) digested with HinfI were ana-
lyzed by 12% polyacrylamide gel electrophoresis and visualized by
staining with ethidium bromide. Lane 1, wild type (G/G, A/A);
Lane 2, heterozygote (G/T, A/G); Lane 3, heterozygote (G/G, A/
G); Lane 4, heterozygote (G/T, G/G); Lane 5, homozygote (T/T,
G/G); Lane 6, heterozygote (G/G, G/G). Molecular weight marker
(left lane).
Table 1
CCK-A receptor genotypes and various body fat content parameters
Genotype Wild (G/G, A/A) and heterozygote types
(n = 1271)
Homozygote (T/T, G/G) type
(n = 25)
P value
Body mass index (kg/m2) 22.8 (0.09) 23.9 (0.78) 0.076
Serum leptin (ng/ml) 5.7 (0.14) 8.8 (2.18) 0.003
Serum insulin (WU/ml) 7.9 (0.13) 9.8 (1.32) 0.038
DXA fat (%) 26.3 (0.20) 29.3 (1.67) 0.041
Mean (S.E.M.). Statistical di¡erences in phenotypic parameters between the two genotypic groups were analyzed by Student’s t-test. Statistical
signi¢cance was assumed with a P value6 0.05.
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